![Daniel M. Jorgensen](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Daniel M. Jorgensen
Director Técnico/Científico/I+D en Ocugen OpCo, Inc. .
Relaciones activas
Nombre | Sexo | Edad | Empresas relacionadas | Colaboración |
---|---|---|---|---|
Kelly Beck | F | 48 |
Ocugen OpCo, Inc.
| 7 años |
Ramesh Kumar | M | 68 |
Ocugen OpCo, Inc.
| 5 años |
Frank Leo | M | 68 |
Ocugen OpCo, Inc.
| 7 años |
Shankar Musunuri | M | 60 |
Ocugen OpCo, Inc.
| 11 años |
Suha Halit Taspolatoglu | M | 62 |
Ocugen OpCo, Inc.
| 7 años |
Manish Potti | M | 38 |
Ocugen OpCo, Inc.
| 8 años |
Junge Zhang | M | 57 |
Ocugen OpCo, Inc.
| 9 años |
Prabhavathi Fernandes | M | 74 | 4 años | |
Vijay Tammara | M | 64 |
Ocugen OpCo, Inc.
| 7 años |
Uday Kompella | M | 57 |
Ocugen OpCo, Inc.
| 11 años |
Kirsten Castillo | F | 51 | 4 años | |
Klaus Romero | M | - |
Critical Path Institute
![]() Critical Path Institute Miscellaneous Commercial ServicesCommercial Services Critical Path Institute is a nonprofit organization established in 2005 as a public and private partnership with the FDA's Critical Path Initiative program. The non-profit company is based in Tucson, AZ, and operates from Ireland with additional staff in multiple other locations. The company's mission is to catalyze the development of new approaches that advance medical innovation and regulatory science, accelerating the path to a healthier world. The company orchestrates the development of drug development tools through an innovative, collaborative approach to the sharing of data and expertise, and accelerate the pace and reduce the costs of medical product development by building consensus among the participating institutions. The company was founded in 2005 by Raymond L. Woosley, Glenn C. Rice. Daniel M. Jorgensen has been the CEO of the company since 2022. | - |
Rasappa Arumugham | M | 73 |
Ocugen OpCo, Inc.
| 7 años |
Gráfico relacional
Relaciones con varias empresas
Antiguas relaciones
Nombre | Sexo | Edad | Empresas relacionadas | Colaboración |
---|---|---|---|---|
Sanjay Subramanian | M | 48 | 3 años | |
Jessica Crespo | F | 47 | 4 años | |
Mark Tobin | M | 50 | 3 años | |
Zorik Spektor | M | 67 | 9 años | |
Joseph Lobacki | M | 65 |
Finch Research & Development LLC
![]() Finch Research & Development LLC Pharmaceuticals: MajorHealth Technology Part of Finch Therapeutics Group, Inc., Finch Research & Development LLC provides biopharmaceutical services. The company is based in Cambridge, MA. Finch Research & Development was acquired by Finch Therapeutics, Inc. on October 23, 2017. | 1 años |
William James Alexander | M | 74 | 1 años | |
Sun Altbach | F | - |
Finch Research & Development LLC
![]() Finch Research & Development LLC Pharmaceuticals: MajorHealth Technology Part of Finch Therapeutics Group, Inc., Finch Research & Development LLC provides biopharmaceutical services. The company is based in Cambridge, MA. Finch Research & Development was acquired by Finch Therapeutics, Inc. on October 23, 2017. | 1 años |
Susan Drexler | F | 54 | 1 años |
Estadísticas
País | Relaciones | % del total |
---|---|---|
Estados Unidos | 21 | 100.00% |
Antigüedad de la relación
Activas
Pasados
Hombre
Mujer
Administradores
Ejecutivos
Origen de las relaciones
- Bolsa de valores
- Insiders
- Daniel M. Jorgensen
- Red Personal